Cover Image
Market Research Report
Product code
1027153

Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, ELISA Analyzer, Luminometer), Service), Allergen (Food, Inhaled, Drug), Test Type (In Vivo, In Vitro), End User - Global Forecast to 2026

Published: | MarketsandMarkets | 288 Pages | Delivery time: 1-2 business days

Price

Back to Top
Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, ELISA Analyzer, Luminometer), Service), Allergen (Food, Inhaled, Drug), Test Type (In Vivo, In Vitro), End User - Global Forecast to 2026
Published: August 31, 2021
MarketsandMarkets
Content info: 288 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The global allergy diagnostics market is projected to USD 8.2 billion by 2026 from USD 4.8 billion in 2021, at a CAGR of 11.1% from 2021 to 2026. The growth of this market is driven owing to the high incidence of allergic diseases and associated heavy economical burden, rising environmental pollution levels, increasing funds by organizations in allergy diagnostics, and the increasing access to healthcare insurance. Also, use of mHealth in allergy diagnosis is anticipated to offer an opportunity for the growth of the market during the forecast period.

"Consumables are expected to hold the largest share of the allergy diagnostics market, by product & service in 2021."

Based on product & service, the allergy diagnostics market is segmented into consumables, instruments, and services. In 2020, the consumables segment accounted for the largest share of the allergy diagnostics market. The large share of the consumables segment can be attributed to the increasing cases of allergies and the need for rapid tests to diagnose allergic conditions. The consumables segment is also expected to witness significant growth during the forecast period.

"In vivo tests are expected to hold the largest share of the allergy diagnostics market, by test type in 2021."

Based on test type, the allergy diagnostics market is segmented into in vivo tests and in vitro tests. In 2020, the in vivo tests segment accounted for the largest share of the allergy diagnostics market. The growth of this segment is mainly driven by the increasing adoption of various in vivo tests, such as skin prick tests. These tests are dependable, safe, convenient, and cost-effective, as compared to in vitro tests.

"Inhaled allergens are expected to hold the largest share of the allergy diagnostics market, by allergen in 2021."

Based on allergens, the allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2020, the inhaled allergens segment accounted for the largest share of the allergy diagnostics market due to the increasing environmental pollution and rising pollen coupled with other factors such as fungus, mold, and dust.

"Diagnostic laboratories are expected to hold the largest share of the allergy diagnostics market, by end user in 2021."

Based on end user, the allergy diagnostics market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end users. In 2020, the diagnostic laboratories segment accounted for the largest share of the market. The large share of the segment can be primarily attributed to the preference for proper diagnosis from a specialist, rising awareness regarding the management of allergic diseases, and the availability of funds for the operation of independent diagnostic laboratories.

"North America commanded the largest share of the allergy diagnostics market in 2021."

Based on region, the allergy diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America commanded the largest share of the allergy diagnostics market. The large share of North America can be attributed to the rising incidence of allergies, favorable reimbursement scenarios for allergy diagnosis, and the availability of supportive initiatives by associations.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level Executives (30%), Directors (20%), and Others (50%)
  • By Region: North America (30%), Europe (25%), AsiaPacific (22%), Middle East & Africa (13%), and Latin America (10%)

Some of the major players operating in this market are Thermo Fisher Scientific, Inc (US), Danaher (US), Minaris Medical America, Inc. (US), Siemens Healthineers AG (US), and Eurofins Scientific (Luxembourg)

List of Companies Profiled in the Report

  • Thermo Fisher Scientific Inc., (US)
  • Siemens Healthineers (Germany)
  • Danaher (US)
  • Omega Diagnostics Group PLC (UK)
  • bioMerieux SA (France)
  • Romer Labs Division Holding (Austria)
  • EUROIMMUN Medizinische Labordiagnostika AG (Germany)
  • HollisterStier Allergy (US)
  • NEOGEN Corporation (US)
  • Eurofins Scientific (Luxembourg)
  • Minaris Medical America, Inc. (US)
  • Stallergenes Greer (UK)
  • HOB Biotech Group Corp., Ltd. (China)
  • HYCOR Biomedical (US)
  • R-Biopharm AG (Germany)
  • AESKU.GROUP GmbH (Germany)
  • ACON Laboratories, Inc. (US)
  • Lincoln Diagnostics, Inc. (US)
  • Astra Biotech GmbH (Germany)
  • Erba Group (UK)

Research Coverage

This report studies the allergy diagnostics market based on product & service, allergen, test type, end user, and region. The report also analyzes factors (such as drivers, restraints, trends, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total allergy diagnostics market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on allergy diagnostics offered by the top 20 players in the allergy diagnostics market. The report analyzes the allergy diagnostics market product & service, allergen, test type, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the allergy diagnostics market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the allergy diagnostics market
Table of Contents
Product Code: MD 2955

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 BOTTOM-UP APPROACH
    • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 6 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 RISK ASSESSMENT/FACTOR ANALYSIS
    • TABLE 1 RISKS
  • 2.7 COVID-19 ECONOMIC ASSESSMENT
  • 2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY

    • FIGURE 10 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD BILLION)
    • FIGURE 11 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2021 VS. 2026 (USD BILLION)
    • FIGURE 12 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2021 VS. 2026 (USD BILLION)
    • FIGURE 13 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2021 VS. 2026 (USD BILLION)
    • FIGURE 14 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2021 VS. 2026 (USD BILLION)

4 PREMIUM INSIGHTS

  • 4.1 ALLERGY DIAGNOSTICS MARKET OVERVIEW
    • FIGURE 15 THE RISING INCIDENCE AND HEAVY ECONOMIC BURDEN OF ALLERGIES IS A KEY FACTOR DRIVING THE MARKET GROWTH
  • 4.2 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET SHARE, BY ALLERGEN (2020)
    • FIGURE 16 THE INHALED ALLERGEN SEGMENT DOMINATED THE MARKET IN 2020
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE ALLERGY DIAGNOSTICS MARKET
    • FIGURE 17 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 ALLERGY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
    • 5.2.1 DRIVERS
      • 5.2.1.1 The high incidence and heavy economic burden of allergic diseases
      • 5.2.1.2 Rising environmental pollution levels
      • 5.2.1.3 Increasing funding initiatives in allergy diagnostics
      • 5.2.1.4 Growing access to health insurance
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Premium costs associated with allergy diagnostic instruments
      • 5.2.2.2 Limited awareness and poor implementation of allergy testing methods
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Use of mHealth in allergy diagnosis
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of allergists
    • 5.2.5 TRENDS
      • 5.2.5.1 Reagent rental agreements
  • 5.3 SUPPLY CHAIN ANALYSIS
    • FIGURE 19 DIRECT DISTRIBUTION, THE PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
  • 5.5 ECOSYSTEM ANALYSIS OF THE ALLERGY DIAGNOSTICS MARKET
    • FIGURE 21 ECOSYSTEM ANALYSIS OF THE ALLERGY DIAGNOSTICS MARKET
    • 5.5.1 ROLE IN THE ECOSYSTEM
    • FIGURE 22 KEY PLAYERS IN THE ALLERGY DIAGNOSTICS MARKET ECOSYSTEM
  • 5.6 PRICING ANALYSIS
    • TABLE 2 AVERAGE SELLING PRICES OF ALLERGY DIAGNOSTICS PRODUCTS
  • 5.7 REGULATORY OVERVIEW
    • 5.7.1 US
    • TABLE 3 US: CLASSIFICATION OF IMMUNOASSAY PRODUCTS
    • FIGURE 23 US: REGULATORY PROCESS FOR IVD DEVICES
    • 5.7.2 CANADA
    • FIGURE 24 CANADA: REGULATORY PROCESS FOR IVD DEVICES IN CANADA
    • 5.7.3 EUROPE
    • TABLE 4 EUROPE: CLASSIFICATION OF IVD DEVICES
      • 5.7.3.1 Europe: regulatory process for IVD devices
    • 5.7.4 JAPAN
      • 5.7.4.1 Japan: regulatory process for IVD devices
    • TABLE 5 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.7.5 CHINA
    • TABLE 6 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.7.6 INDIA
      • 5.7.6.1 India: regulatory process for IVD devices
    • 5.7.7 INDONESIA
    • TABLE 7 INDONESIA: REGISTRATION PROCESS FOR IVD DEVICES
    • 5.7.8 RUSSIA
    • TABLE 8 RUSSIA: CLASSIFICATION OF IVD DEVICES
    • 5.7.9 SAUDI ARABIA
    • TABLE 9 SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.7.10 MEXICO
      • 5.7.10.1 Mexico: regulatory process for IVD devices
    • TABLE 10 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.7.11 BRAZIL
      • 5.7.11.1 Brazil: regulatory process for IVD devices
    • 5.7.12 SOUTH KOREA
    • TABLE 11 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • 5.8 TRADE ANALYSIS
    • 5.8.1 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2016-2020 (USD THOUSAND)
    • 5.8.2 EXPORT DATA FOR HS CODE 902750, BY COUNTRY, 2017-2019 (USD THOUSAND)
    • 5.8.3 EXPORT DATA FOR HS CODE 902750, BY COUNTRY, 2016-2020
    • 5.8.4 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2016-2020
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT ANALYSIS: LUMINOMETERS
  • 5.10 TECHNOLOGY ANALYSIS
  • 5.11 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 12 HIGH CONSOLIDATION IN THE MARKET TO RESTRICT THE ENTRY OF NEW PLAYERS
    • 5.11.1 DEGREE OF COMPETITION
    • 5.11.2 BARGAINING POWER OF SUPPLIERS
    • 5.11.3 BARGAINING POWER OF BUYERS
    • 5.11.4 THREAT OF SUBSTITUTES
    • 5.11.5 THREAT OF NEW ENTRANTS
  • 5.12 COVID-19 IMPACT ANALYSIS FOR THE ALLERGY DIAGNOSTICS MARKET
  • 5.13 RANGES/ SCENARIOS
    • 5.13.1 ALLERGY DIAGNOSTICS MARKET FORECAST
    • FIGURE 25 REALISTIC SCENARIO OF THE ALLERGY DIAGNOSTICS MARKET
    • FIGURE 26 PESSIMISTIC SCENARIO OF THE ALLERGY DIAGNOSTICS MARKET
    • FIGURE 27 OPTIMISTIC SCENARIO OF THE ALLERGY DIAGNOSTICS MARKET
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
    • 5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR ALLERGY DIAGNOSTICS MANUFACTURERS
    • FIGURE 28 REVENUE SHIFT FOR ALLERGY DIAGNOSTICS MARKET

6 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 13 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 14 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
  • 6.2 CONSUMABLES
    • 6.2.1 CONSUMABLES ARE THE MOST WIDELY USED PRODUCTS FOR ALLERGY TESTING
    • TABLE 15 ALLERGY DIAGNOSTICS CONSUMABLES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 16 ALLERGY DIAGNOSTICS CONSUMABLES MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 17 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 18 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 19 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 20 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.1 IMMUNOASSAY ANALYZERS
      • 6.3.1.1 Immunoassay analyzers are highly preferred for allergy diagnostics
    • TABLE 21 ALLERGY DIAGNOSTICS FOR IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 22 ALLERGY DIAGNOSTICS FOR IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.2 ELISA ANALYZERS
      • 6.3.2.1 The precision offered by ELISA tests to propel the growth of the segment
    • TABLE 23 ALLERGY DIAGNOSTICS FOR ELISA ANALYZERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 24 ALLERGY DIAGNOSTICS FOR ELISA ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.3 LUMINOMETERS
      • 6.3.3.1 Luminometers are convenient to use, thus leading to their increased adoption
    • TABLE 25 ALLERGY DIAGNOSTICS FOR LUMINOMETERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 26 ALLERGY DIAGNOSTICS FOR LUMINOMETERS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.4 OTHER INSTRUMENTS
    • TABLE 27 ALLERGY DIAGNOSTICS FOR OTHER INSTRUMENTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 28 ALLERGY DIAGNOSTICS FOR OTHER INSTRUMENTS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.4 SERVICES
    • 6.4.1 RISING CASES OF ALLERGIES TO DRIVE THE GROWTH OF THE SERVICES SEGMENT
    • TABLE 29 ALLERGY DIAGNOSTICS SERVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 30 ALLERGY DIAGNOSTICS SERVICES MARKET, BY REGION, 2020-2026 (USD MILLION)

7 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 31 ALLERGY TESTS ADVANTAGES AND LIMITATIONS
    • TABLE 32 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 33 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
  • 7.2 IN VIVO TESTS
    • TABLE 34 IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 35 IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 36 IN VIVO TESTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 37 IN VIVO TESTS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 7.2.1 SKIN PRICK TESTS
      • 7.2.1.1 Skin prick tests are the most widely preferred in vivo allergy tests
    • TABLE 38 SKIN PRICK TESTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 39 SKIN PRICK TESTS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 7.2.2 PATCH TESTS
      • 7.2.2.1 Patch tests help in the diagnosis of contact dermatitis, unlike the skin prick test
    • TABLE 40 PATCH TESTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 41 PATCH TESTS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 7.2.3 OTHER IN VIVO TESTS
    • TABLE 42 OTHER IN VIVO TESTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 43 OTHER IN VIVO TESTS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 7.3 IN VITRO TESTS
    • 7.3.1 IN VITRO ALLERGY TESTS ARE SET TO WITNESS SIGNIFICANT GROWTH DURING THE FORECAST PERIOD
    • TABLE 44 IN VITRO TESTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 45 IN VITRO TESTS MARKET, BY REGION, 2020-2026 (USD MILLION)

8 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN

  • 8.1 INTRODUCTION
    • TABLE 46 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 47 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
  • 8.2 INHALED ALLERGENS
    • 8.2.1 INHALED ALLERGENS DOMINATED THE MARKET IN 2020
    • TABLE 48 INHALED ALLERGENS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 49 INHALED ALLERGENS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 8.3 FOOD ALLERGENS
    • 8.3.1 FOOD ALLERGY IS FOUND TO BE MORE PREVALENT AMONG CHILDREN
    • TABLE 50 SPECIFIC FOOD-INDUCED ALLERGIC CONDITIONS
    • TABLE 51 FOOD ALLERGENS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 52 FOOD ALLERGENS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 8.4 DRUG ALLERGENS
    • 8.4.1 THE DRUG ALLERGY SEGMENT IS EXPECTED TO WITNESS CONSIDERABLE GROWTH DURING THE FORECAST PERIOD
    • TABLE 53 DRUG ALLERGENS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 54 DRUG ALLERGENS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 8.5 OTHER ALLERGENS
    • TABLE 55 OTHER ALLERGENS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 56 OTHER ALLERGENS MARKET, BY REGION, 2020-2026 (USD MILLION)

9 ALLERGY DIAGNOSTICS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 57 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 58 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 9.2 DIAGNOSTIC LABORATORIES
    • 9.2.1 DIAGNOSTIC LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE END-USER MARKET IN 2020
    • TABLE 59 ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 60 ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020-2026 (USD MILLION)
  • 9.3 HOSPITAL-BASED LABORATORIES
    • 9.3.1 HOSPITAL-BASED LABORATORIES ARE MORE ACCESSIBLE TO PATIENTS AND OFFER RAPID RESULTS
    • TABLE 61 ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 62 ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2020-2026 (USD MILLION)
  • 9.4 ACADEMIC RESEARCH INSTITUTES
    • 9.4.1 GRANTS OFFERED BY ORGANIZATIONS TO SUPPORT THE GROWTH OF THIS SEGMENT
    • TABLE 63 ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 64 ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020-2026 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 65 ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 66 ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2020-2026 (USD MILLION)

10 ALLERGY DIAGNOSTICS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 67 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 68 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 29 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SNAPSHOT
    • TABLE 69 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 70 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 71 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 72 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 73 NORTH AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 74 NORTH AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 75 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 76 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 77 NORTH AMERICA: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 78 NORTH AMERICA: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 79 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 80 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 81 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 82 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 The economic burden associated with allergies is expected to drive the growth of the market
    • TABLE 83 US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 84 US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 85 US: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 86 US: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 87 US: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 88 US: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 89 US: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 90 US: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 91 US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 92 US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 93 US: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 94 US: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Rising funding activities in allergy diagnostics to drive the market growth in Canada
    • FIGURE 30 ALLERGIES, BY TYPE, POPULATION AGED 12 AND OLDER, CANADA (2017)
    • TABLE 95 CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 96 CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 97 CANADA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 98 CANADA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 99 CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 100 CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 101 CANADA: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 102 CANADA: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 103 CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 104 CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 105 CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 106 CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 107 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 108 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 109 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 110 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 111 EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 112 EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 113 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 114 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 115 EUROPE: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 116 EUROPE: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 117 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 118 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 119 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 120 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany accounted for the largest share of the EU market in 2020
    • TABLE 121 COMPARATIVE ANALYSIS OF ALLERGENS
    • TABLE 122 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 123 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 124 GERMANY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 125 GERMANY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 126 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 127 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 128 GERMANY: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 129 GERMANY: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 130 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 131 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 132 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 133 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Increasing prevalence of food anaphylaxis in the UK to support the market growth
    • TABLE 134 UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 135 UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 136 UK: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 137 UK: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 138 UK: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 139 UK: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 140 UK: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 141 UK: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 142 UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 143 UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 144 UK: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 145 UK: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Availability of reimbursements in France to support the growth of the market
    • TABLE 146 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 147 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 148 FRANCE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 149 FRANCE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 150 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 151 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 152 FRANCE: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 153 FRANCE: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 154 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 155 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 156 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 157 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Presence of allergy diagnostic organizations in Italy to support allergy diagnosis research & demand for products
    • TABLE 158 ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 159 ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 160 ITALY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 161 ITALY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 162 ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 163 ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 164 ITALY: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 165 ITALY: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 166 ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 167 ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 168 ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 169 ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 The government undertakes initiatives for the development of the healthcare system in Spain to support the market growth
    • TABLE 170 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 171 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 172 SPAIN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 173 SPAIN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 174 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 175 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 176 SPAIN: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 177 SPAIN: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 178 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 179 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 180 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 181 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.6 REST OF EUROPE (ROE)
    • TABLE 182 ROE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 183 ROE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 184 ROE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 185 ROE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 186 ROE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 187 ROE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 188 ROE: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 189 ROE: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 190 ROE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 191 ROE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 192 ROE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 193 ROE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 31 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET SNAPSHOT
    • TABLE 194 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 195 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 196 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 197 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 198 ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 199 ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 200 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 201 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 202 ASIA PACIFIC: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 203 ASIA PACIFIC: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 204 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 205 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 206 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 207 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 China accounted for the largest share of the allergy diagnostics market in the Asia Pacific
    • TABLE 208 CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 209 CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 210 CHINA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 211 CHINA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 212 CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 213 CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 214 CHINA: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 215 CHINA: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 216 CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 217 CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 218 CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 219 CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Increasing prevalence of allergies among children to propel the demand for allergy diagnostics in Japan
    • TABLE 220 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 221 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 222 JAPAN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 223 JAPAN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 224 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 225 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 226 JAPAN: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 227 JAPAN: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 228 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 229 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 230 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 231 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Limited awareness regarding allergy management to limit the growth of the market
    • TABLE 232 INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 233 INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 234 INDIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 235 INDIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 236 INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 237 INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 238 INDIA: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 239 INDIA: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 240 INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 241 INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 242 INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 243 INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 High prevalence of food allergy to propel the growth of the allergy diagnostics market in Australia
    • TABLE 244 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 245 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 246 AUSTRALIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 247 AUSTRALIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 248 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 249 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 250 AUSTRALIA: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 251 AUSTRALIA: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 252 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 253 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 254 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 255 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 256 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 257 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 258 ROAPAC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 259 ROAPAC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 260 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 261 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 262 ROAPAC: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 263 ROAPAC: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 264 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 265 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 266 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 267 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 268 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 269 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 270 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 271 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 272 LATIN AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 273 LATIN AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 274 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 275 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 276 LATIN AMERICA: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 277 LATIN AMERICA: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 278 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 279 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 280 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 281 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Brazil accounted for the largest share of the allergy diagnostics market in Latin America
    • TABLE 282 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 283 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 284 BRAZIL: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 285 BRAZIL: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 286 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 287 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 288 BRAZIL: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 289 BRAZIL: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 290 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 291 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 292 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 293 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 The availability of allergy education training to support the growth of the market in Mexico
    • TABLE 294 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 295 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 296 MEXICO: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 297 MEXICO: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 298 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 299 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 300 MEXICO: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 301 MEXICO: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 302 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 303 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 304 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 305 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
      • 10.5.3.1 The rising concentration of pollen in the environment is expected to propel the demand for allergy diagnostics in the region
    • TABLE 306 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 307 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 308 ROLATAM: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 309 ROLATAM: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 310 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 311 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 312 ROLATAM: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 313 ROLATAM: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 314 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 315 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 316 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 317 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA (MEA)
    • 10.6.1 RISING INCIDENCES OF ALLERGY RHINITIS TO SUPPORT THE MARKET GROWTH IN THE MEA REGION
    • TABLE 318 MEA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 319 MEA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
    • TABLE 320 MEA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 321 MEA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 322 MEA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 323 MEA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 324 MEA: IN VIVO TESTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 325 MEA: IN VIVO TESTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 326 MEA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016-2019 (USD MILLION)
    • TABLE 327 MEA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020-2026 (USD MILLION)
    • TABLE 328 MEA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 329 MEA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE MARKET
  • 11.3 REVENUE ANALYSIS
    • FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN THE ALLERGY DIAGNOSTICS MARKET
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 33 ALLERGY DIAGNOSTICS MARKET SHARE ANALYSIS (2020)
    • TABLE 330 ALLERGY DIAGNOSTICS MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 34 VENDOR DIVE: ALLERGY DIAGNOSTICS MARKET
  • 11.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 35 ALLERGY DIAGNOSTICS MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020
  • 11.7 COMPANY FOOTPRINT
    • TABLE 331 COMPANY FOOTPRINT
    • TABLE 332 COMPANY PRODUCT & SERVICE FOOTPRINT
    • TABLE 333 COMPANY TEST TYPE FOOTPRINT
    • TABLE 334 COMPANY GEOGRAPHICAL FOOTPRINT
  • 11.8 COMPETITIVE SCENARIO AND TRENDS
    • 11.8.1 DEALS
    • TABLE 335 DEALS, JANUARY 2017-JULY 2021
    • 11.8.2 PRODUCT LAUNCHES
    • TABLE 336 PRODUCT LAUNCHES, JANUARY 2017-JULY 2021
    • 11.8.3 EXPANSIONS
    • TABLE 337 EXPANSIONS, JANUARY 2017-JULY 2021
    • 11.8.4 OTHER DEVELOPMENTS
    • TABLE 338 OTHER DEVELOPMENTS, JANUARY 2017-JULY 2021

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 THERMO FISHER SCIENTIFIC INC.
    • TABLE 339 THERMO FISHER SCIENTIFIC INC. INC: BUSINESS OVERVIEW
    • FIGURE 36 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
    • 12.1.2 DANAHER
    • TABLE 340 DANAHER: BUSINESS OVERVIEW
    • FIGURE 37 DANAHER: COMPANY SNAPSHOT (2020)
    • 12.1.3 MINARIS MEDICAL AMERICA, INC.
    • TABLE 341 MINARIS MEDICAL AMERICA, INC.: BUSINESS OVERVIEW
    • FIGURE 38 HITACHI CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2019)
    • 12.1.4 SIEMENS HEALTHINEERS AG
    • TABLE 342 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
    • FIGURE 39 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2020)
    • 12.1.5 EUROFINS SCIENTIFIC
    • TABLE 343 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 40 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)
    • 12.1.6 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
    • TABLE 344 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: BUSINESS OVERVIEW
    • FIGURE 41 PERKINELMER: COMPANY SNAPSHOT (2020)
    • 12.1.7 BIOMERIEUX SA
    • TABLE 345 BIOMERIEUX SA: BUSINESS OVERVIEW
    • FIGURE 42 BIOMERIEUX SA: COMPANY SNAPSHOT (2020)
    • 12.1.8 STALLERGENES GREER LTD
    • TABLE 346 STALLERGENES GREER LTD.: BUSINESS OVERVIEW
    • 12.1.9 ROMER LABS DIVISION HOLDING GMBH
    • TABLE 347 ROMER LABS DIVISION HOLDING GMBH: BUSINESS OVERVIEW
    • FIGURE 43 DSM ROYAL: COMPANY SNAPSHOT (2020)
    • 12.1.10 NEOGEN CORPORATION
    • TABLE 348 NEOGEN CORPORATION: BUSINESS OVERVIEW
    • FIGURE 44 NEOGEN CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.11 HOLLISTERSTIER ALLERGY
    • TABLE 349 HOLLISTERSTIER ALLERGY: BUSINESS OVERVIEW
    • FIGURE 45 JUBILANT PHARMA LIMITED: COMPANY SNAPSHOT (2020)
    • 12.1.12 OMEGA DIAGNOSTICS GROUP PLC
    • TABLE 350 OMEGA DIAGNOSTICS GROUP PLC : BUSINESS OVERVIEW
    • FIGURE 46 OMEGA DIAGNOSTICS GROUP PLC: COMPANY SNAPSHOT (2020)
  • 12.2 OTHER PLAYERS
    • 12.2.1 HOB BIOTECH GROUP CORP., LTD.
    • TABLE 351 HOB BIOTECH GROUP CORP., LTD.: BUSINESS OVERVIEW
    • 12.2.2 HYCOR BIOMEDICAL
    • TABLE 352 HYCOR BIOMEDICAL: BUSINESS OVERVIEW
    • 12.2.3 LINCOLN DIAGNOSTICS, INC.
    • TABLE 353 LINCOLN DIAGNOSTICS, INC.: BUSINESS OVERVIEW
    • 12.2.4 R-BIOPHARM AG
    • TABLE 354 R-BIOPHARM AG: BUSINESS OVERVIEW
    • 12.2.5 ASTRA BIOTECH GMBH
    • TABLE 355 ASTRA BIOTECH GMBH: BUSINESS OVERVIEW
    • 12.2.6 ERBA GROUP
    • TABLE 356 ERBA GROUP: BUSINESS OVERVIEW
    • 12.2.7 AESKU.GROUP GMBH
    • TABLE 357 AESKU.GROUP GMBH: BUSINESS OVERVIEW
    • 12.2.8 ACON LABORATORIES, INC.
    • TABLE 358 ACON LABORATORIES, INC.: BUSINESS OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS